IP Library Granted Patent US 12,453,519
Granted Patent B2
US 12,453,519 · App. 18/436,453 · Granted Oct 28, 2025

System and method for assessing and monitoring the hemodynamic condition of a patient

Inventors: Ashwin Belle (Ann Arbor, MI); Bryce Benson (Ann Arbor, MI); Mark Salamango (Ann Arbor, MI)
Assignee: AIRSTRIP OPERATIONS, LLC
A61B5/746A61B5/02405A61B5/0245A61B5/339A61B5/352A61B5/366A61B5/726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,453,519
App. No.
18/436,453
Granted
Oct 28, 2025
Kind
B2
Abstract

A system for assessing and monitoring the hemodynamic condition of a patient includes a signal processor and optionally a premise processing system. Additionally, the system can include a biosignal detection device, memory, a display, and any other suitable component. A method for assessing and monitoring the hemodynamic condition of a patient includes: receiving input data; determining a set of windows based on the input data; preprocessing each of the set of windows; processing each of the set of windows; determining a set of features for each of the set of windows; determining a hemodynamic condition for each window based on the set of features; and presenting the hemodynamic condition to a user.

Claims (35)

1. A method for monitoring of a physiological condition of a patient, the method comprising:

at a computing system, receiving a physiological signal stream;

at the computing system, determining a set of labels associated with the physiological signal stream, comprising:

when a first low data quality criterion of a set of criteria is met by a portion of the physiological signal stream, assigning a first label to the portion of the physiological signal stream;

determining a set of features based on a set of waveforms of the physiological signal stream, wherein the set of features are not determined based on waveforms associated with the portion of the physiological signal stream associated with the first label;

determining a risk classification of the patient based on the set of features; and

in response to determining the risk classification, automatically initiating administration of a drug delivery to the patient at a therapeutic delivery system.

2. The method of claim 1 , wherein the set of features comprises a set of consolidated waveform peaks.

3. The method of claim 2 , wherein the set of consolidated waveform peaks correspond to hemodynamic instability and can comprise at least one of: P, Q, R, S peaks (ECG), peaks in a pulse oximeter signal, an arterial blood pressure (ABP) waveform, an intracranial waveform, or an electroencephalogram (EEG) signal waveform.

4. The method of claim 2 , wherein the set of consolidated waveform peaks are determined through a wavelet transform peak detection process.

5. The method of claim 2 , wherein the set of consolidated waveform peaks are determined through a taut string detection process.

6. The method of claim 1 , wherein the set of features comprise at least one of: a heart rate variability metric, or a morphology metric.

7. The method of claim 1 , further comprising, when no portion of the physiological signal stream meets a criterion of the set of criteria: assigning one of a second and third label to the physiological signal stream based on a set of physiological stability values.

8. The method of claim 1 , wherein the first low data quality criterion comprises a missing data criterion.

9. The method of claim 1 , wherein the first low data quality criterion comprises a noisy data criterion.

10. The method of claim 1 , wherein the set of features comprises a set of patient specific waveform features.

11. The method of claim 10 , wherein the patient specific waveform features comprise at least one of: a set of waveform outliers, a set of waveform shapes, or a set of waveform amplitudes.

12. The method of claim 10 , further comprising:

checking the physiological signal stream for a second low data quality criterion;

when the second low data quality criterion is met by a portion of the physiological signal stream, assigning a second label to the physiological signal stream.

13. A method for monitoring a physiological condition of a patient, the method comprising:

at a computing system, processing a physiological signal stream comprising a set of waveforms, wherein processing the physiological signal stream comprises:

checking the physiological signal stream for portions of the physiological signal stream that satisfy any of a set of criteria associated with data quality;

when the set of criteria are not satisfied:

determining a set of features based on the set of waveforms, wherein the set of features are not determined based on waveforms associated with the portions of the physiological signal stream that satisfy any of the set of criteria;

determining a set of physiological stability values based on the set of features;

determining a risk classification of the patient based on the set of physiological stability values; and

in response to determining the risk classification, automatically initiating administration of a therapeutic treatment to the patient at a therapeutic delivery system.

14. The method of claim 13 , further comprising determining a set of qualitative signal quality labels for the physiological signal stream, wherein when any of the set of data criteria are satisfied, a corresponding label of the set of qualitative signal quality labels indicates a low data quality of a portion of the physiological signal stream.

15. The method of claim 13 , wherein the therapeutic delivery system comprises a therapeutic delivery mechanism and a processor, wherein the processor is configured to control administration of the therapeutic treatment to the patient based on the risk classification.

16. The method of claim 13 , wherein the set of features are determined based on individual signals within the set of waveforms and averaged signals within the set of waveforms.

17. The method of claim 13 , wherein processing the physiological signal stream is performed for consecutive windows of data within the physiological signal stream, further comprising, if set of criteria are satisfied for a window, terminating processing of the window.

18. The method of claim 13 , further comprising, when at least one of the set of criteria is satisfied, assigning a low data quality label to the physiological signal stream.

19. The method of claim 13 , wherein the physiological signal stream comprises an electrocardiogram (ECG) signal stream.

20. The method of claim 13 , wherein the risk classification is associated with at least one of: a potential cardiac event, a predicted time until hemodynamic instability, or a patient deterioration event.

Assignments (3)
SECURITY INTEREST Recorded Oct 6, 2025
From: AIRSTRIP IP HOLDINGS, LLC; AIRSTRIP OPERATIONS, LLC; DECISIO HEALTH, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 072480/0096 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2025
From: FIFTH EYE INC.
To: AIRSTRIP OPERATIONS, LLC
Reel/Frame 070847/0700 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2024
From: BELLE, ASHWIN; BENSON, BRYCE; SALAMANGO, MARK
To: FIFTH EYE INC.
Reel/Frame 066533/0705 →